Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Siemers currently holds 255,371 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Siemers has been a net seller of ABOS stock. They have purchased $0 and sold $38.7K worth of shares.
Eric Siemers's most recent insider trade was on Jan 22, 2026, when they sold 895 shares at $1.82 per share.
Eric Siemers serves as Executive at Acumen Pharmaceuticals, Inc. (ABOS). They have executed 10 insider transactions totaling $38.7K over their tenure at the company.
Eric Siemers holds the position of Executive at Acumen Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Eric Siemers has shown a selling trading pattern, with $0 in total purchases and $38.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Siemers was on Jan 6, 2026, when they sold $13.4K worth of ABOS shares. This transaction involved 6,834 shares at $1.97 per share.
Eric Siemers currently owns 255,371 shares of Acumen Pharmaceuticals, Inc. (ABOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Siemers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Siemers has 10 Form 4 filings on record as an insider at Acumen Pharmaceuticals, Inc..
Set alerts for Eric Siemers and 40,000+ other insiders.